(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731503 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ROCK2 mRNA CTD PMID:22079256 (S)-amphetamine affects expression ISO RGD:11243 6480464 Dextroamphetamine affects the expression of ROCK2 mRNA CTD PMID:12558987 1,2-dimethylhydrazine multiple interactions ISO RGD:11243 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ROCK2 mRNA CTD PMID:22206623 1,3,5-trinitro-1,3,5-triazinane decreases expression EXP 6480464 cyclonite results in decreased expression of ROCK2 mRNA CTD PMID:25559034 17beta-estradiol affects expression ISO RGD:11243 6480464 Estradiol affects the expression of ROCK2 mRNA CTD PMID:15598610 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11243 6480464 Tetrachlorodibenzodioxin affects the expression of ROCK2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ROCK2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ROCK2 mRNA CTD PMID:34747641 2,4,6-tribromophenol increases expression ISO RGD:731503 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ROCK2 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:11243 6480464 n-butoxyethanol results in increased expression of ROCK2 mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine increases expression ISO RGD:11243 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ROCK2 mRNA CTD PMID:19285098 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:11243 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ROCK2 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731503 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ROCK2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROCK2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:11243 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ROCK2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases methylation ISO RGD:731503 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of ROCK2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:11243 6480464 Fenretinide results in decreased expression of ROCK2 mRNA CTD PMID:28973697 aflatoxin B1 increases expression ISO RGD:731503 6480464 Aflatoxin B1 results in increased expression of ROCK2 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:731503 6480464 Aflatoxin B1 results in decreased methylation of ROCK2 gene CTD PMID:27153756 Aflatoxin B2 alpha decreases methylation ISO RGD:731503 6480464 aflatoxin B2 results in decreased methylation of ROCK2 intron CTD PMID:30157460 Alkannin multiple interactions ISO RGD:731503 6480464 alkannin inhibits the reaction [lipopolysaccharide more ... CTD PMID:30924981 Alkannin multiple interactions ISO RGD:11243 6480464 alkannin inhibits the reaction [lipopolysaccharide more ... CTD PMID:30924981 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ROCK2 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:731503 6480464 Antirheumatic Agents results in increased expression of ROCK2 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:731503 6480464 aristolochic acid I results in increased expression of ROCK2 protein CTD PMID:33212167 aristolochic acid A decreases expression ISO RGD:731503 6480464 aristolochic acid I results in decreased expression of ROCK2 mRNA CTD PMID:33212167 arsane increases response to substance ISO RGD:731503 6480464 ROCK2 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsenic atom increases response to substance ISO RGD:731503 6480464 ROCK2 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsenite(3-) decreases expression ISO RGD:11243 6480464 arsenite results in decreased expression of ROCK2 mRNA CTD PMID:33053406 arsenite(3-) multiple interactions ISO RGD:731503 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ROCK2 mRNA], arsenite inhibits the reaction [G3BP1 protein binds to ROCK2 protein] CTD PMID:32406909 benzo[a]pyrene increases expression ISO RGD:11243 6480464 Benzo(a)pyrene results in increased expression of ROCK2 mRNA CTD PMID:20127859 benzo[a]pyrene affects methylation ISO RGD:731503 6480464 Benzo(a)pyrene affects the methylation of ROCK2 intron, Benzo(a)pyrene affects the methylation of ROCK2 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:11243 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ROCK2 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:731503 6480464 Benzo(a)pyrene metabolite results in increased expression of ROCK2 mRNA CTD PMID:26314263 benzo[a]pyrene decreases expression ISO RGD:731503 6480464 Benzo(a)pyrene results in decreased expression of ROCK2 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene decreases expression ISO RGD:11243 6480464 Benzo(a)pyrene results in decreased expression of ROCK2 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:731503 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[b]fluoranthene multiple interactions ISO RGD:11243 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ROCK2 mRNA CTD PMID:27858113 bisphenol A increases expression ISO RGD:11243 6480464 bisphenol A results in increased expression of ROCK2 mRNA CTD PMID:26063408 bisphenol A increases methylation ISO RGD:731503 6480464 bisphenol A results in increased methylation of ROCK2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:11243 6480464 bisphenol A results in decreased expression of ROCK2 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ROCK2 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ROCK2 mRNA CTD PMID:33296240 bisphenol A multiple interactions ISO RGD:731503 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ROCK2 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ROCK2 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:731503 6480464 bisphenol B results in increased expression of ROCK2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:731503 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROCK2 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:731503 6480464 bisphenol F results in increased expression of ROCK2 protein CTD PMID:34186270 BQ 123 multiple interactions EXP 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) co-treated with BQ 788] inhibits the reaction [[5, 7-dihydroxy-6-methoxy-2-phenylchromen-4-one co-treated with Lipopolysaccharides] results in increased phosphorylation of ROCK2 protein] CTD PMID:26694894 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ROCK2 protein CTD PMID:28903499 caffeine decreases phosphorylation ISO RGD:731503 6480464 Caffeine results in decreased phosphorylation of ROCK2 protein CTD PMID:35688186 cannabidiol multiple interactions ISO RGD:731503 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of ROCK2 mRNA CTD PMID:30096889 carbamazepine affects expression ISO RGD:731503 6480464 Carbamazepine affects the expression of ROCK2 mRNA CTD PMID:24752500 carbon nanotube multiple interactions ISO RGD:731503 6480464 ROCK2 protein promotes the reaction [Nanotubes, Carbon results in increased secretion of IL1B protein] CTD PMID:24760326 carbon nanotube decreases expression ISO RGD:11243 6480464 Nanotubes, Carbon analog results in decreased expression of ROCK2 mRNA CTD PMID:25554681 chloropicrin affects expression ISO RGD:731503 6480464 chloropicrin affects the expression of ROCK2 mRNA CTD PMID:26352163 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of ROCK2 protein CTD PMID:34058248 chromium(6+) decreases expression ISO RGD:731503 6480464 chromium hexavalent ion results in decreased expression of ROCK2 mRNA CTD PMID:30690063 chrysene multiple interactions ISO RGD:11243 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ROCK2 mRNA CTD PMID:27858113 cisplatin multiple interactions ISO RGD:731503 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ROCK2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:731503 6480464 Cisplatin results in decreased expression of ROCK2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:731503 6480464 cobaltous chloride results in decreased expression of ROCK2 mRNA CTD PMID:19320972 cobalt dichloride increases expression ISO RGD:731503 6480464 cobaltous chloride results in increased expression of ROCK2 mRNA CTD PMID:26314263 cocaine affects expression EXP 6480464 Cocaine affects the expression of ROCK2 mRNA CTD PMID:20187946 copper atom increases expression EXP 6480464 Copper results in increased expression of ROCK2 mRNA CTD PMID:22465980 copper(0) increases expression EXP 6480464 Copper results in increased expression of ROCK2 mRNA CTD PMID:22465980 copper(II) sulfate increases expression ISO RGD:731503 6480464 Copper Sulfate results in increased expression of ROCK2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:731503 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA CTD PMID:19167446 crocidolite asbestos multiple interactions ISO RGD:731503 6480464 ROCK2 protein promotes the reaction [Asbestos, Crocidolite results in increased secretion of IL1B protein] CTD PMID:24760326 crocidolite asbestos decreases expression ISO RGD:11243 6480464 Asbestos, Crocidolite results in decreased expression of ROCK2 mRNA CTD PMID:29279043 DDT decreases expression EXP 6480464 DDT results in decreased expression of ROCK2 mRNA CTD PMID:30207508 decabromodiphenyl ether increases expression ISO RGD:731503 6480464 decabromobiphenyl ether results in increased expression of ROCK2 protein CTD PMID:31675489 dexamethasone increases expression ISO RGD:731503 6480464 Dexamethasone results in increased expression of ROCK2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:11243 6480464 Dexamethasone inhibits the reaction [lipopolysaccharide more ... CTD PMID:30924981 dexamethasone multiple interactions ISO RGD:731503 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ROCK2 mRNA more ... CTD PMID:28628672 , PMID:30924981 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ROCK2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:11243 6480464 Dibutyl Phthalate results in increased expression of ROCK2 mRNA CTD PMID:17361019 , PMID:21266533 diclofenac affects expression ISO RGD:731503 6480464 Diclofenac affects the expression of ROCK2 mRNA CTD PMID:24752500 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of ROCK2 mRNA CTD PMID:16122865 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ROCK2 mRNA CTD PMID:26476374 dioxygen multiple interactions ISO RGD:731503 6480464 ROCK2 protein affects the reaction [Oxygen deficiency results in increased expression of HIF1A protein] CTD PMID:30831131 dioxygen multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of ROCK2 mRNA] CTD PMID:26476374 emodin decreases expression ISO RGD:731503 6480464 Emodin results in decreased expression of ROCK2 mRNA CTD PMID:16045814 endosulfan decreases expression ISO RGD:731503 6480464 Endosulfan results in decreased expression of ROCK2 mRNA CTD PMID:28108160 , PMID:30090376 Enterolactone multiple interactions ISO RGD:731503 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:731503 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ROCK2 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:11243 6480464 epoxiconazole results in decreased expression of ROCK2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:11243 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ROCK2 mRNA CTD PMID:30517762 fasudil multiple interactions ISO RGD:731503 6480464 fasudil inhibits the reaction [lipopolysaccharide more ... CTD PMID:30924981 fasudil multiple interactions ISO RGD:11243 6480464 fasudil inhibits the reaction [Acetaminophen results in increased expression of ROCK2 protein] more ... CTD PMID:30924981 , PMID:34078832 fasudil decreases activity EXP 6480464 fasudil results in decreased activity of ROCK2 protein CTD PMID:10998351 folic acid decreases expression ISO RGD:11243 6480464 Folic Acid results in decreased expression of ROCK2 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:11243 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ROCK2 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:731503 6480464 Formaldehyde results in decreased expression of ROCK2 mRNA CTD PMID:23649840 fulvestrant increases methylation ISO RGD:731503 6480464 Fulvestrant results in increased methylation of ROCK2 gene CTD PMID:31601247 geldanamycin increases expression ISO RGD:731503 6480464 geldanamycin results in increased expression of ROCK2 mRNA CTD PMID:26705709 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ROCK2 protein CTD PMID:24552547 glycyrrhetinate multiple interactions ISO RGD:731503 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of ROCK2 mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of ROCK2 protein] CTD PMID:31325423 glycyrrhetinic acid multiple interactions ISO RGD:731503 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of ROCK2 mRNA], 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of ROCK2 protein] CTD PMID:31325423 guanosine 5'-[gamma-thio]triphosphate affects localization EXP 6480464 Guanosine 5'-O-(3-Thiotriphosphate) affects the localization of ROCK2 protein CTD PMID:12960549 guanosine 5'-[gamma-thio]triphosphate multiple interactions EXP 6480464 sevoflurane inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) affects the localization of ROCK2 protein] CTD PMID:12960549 hexadecanoic acid multiple interactions ISO RGD:731503 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ROCK2 protein, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ROCK2 protein CTD PMID:30547786 indometacin decreases expression ISO RGD:731503 6480464 Indomethacin results in decreased expression of ROCK2 mRNA CTD PMID:16984733 indometacin multiple interactions ISO RGD:731503 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ROCK2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROCK2 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:731503 6480464 Ivermectin results in decreased expression of ROCK2 protein CTD PMID:32959892 leflunomide increases expression ISO RGD:731503 6480464 leflunomide results in increased expression of ROCK2 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions EXP 6480464 [5 more ... CTD PMID:26694894 methylmercury(1+) increases expression ISO RGD:731503 6480464 methylmercury II results in increased expression of ROCK2 mRNA CTD PMID:26314263 miconazole decreases expression ISO RGD:11243 6480464 Miconazole results in decreased expression of ROCK2 mRNA CTD PMID:27462272 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of ROCK2 protein CTD PMID:10998351 ochratoxin A increases expression ISO RGD:731503 6480464 ochratoxin A metabolite results in increased expression of ROCK2 mRNA, ochratoxin A results in increased expression of ROCK2 mRNA CTD PMID:26314263 oleic acid multiple interactions ISO RGD:731503 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ROCK2 protein, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ROCK2 protein CTD PMID:30547786 oroxylin A multiple interactions EXP 6480464 [5 more ... CTD PMID:26694894 ouabain multiple interactions ISO RGD:731503 6480464 benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK2 protein] CTD PMID:20661774 ouabain increases cleavage ISO RGD:731503 6480464 Ouabain results in increased cleavage of ROCK2 protein CTD PMID:20661774 paracetamol affects expression ISO RGD:11243 6480464 Acetaminophen affects the expression of ROCK2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ROCK2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:11243 6480464 Acetaminophen results in increased expression of ROCK2 protein CTD PMID:34078832 paracetamol multiple interactions ISO RGD:11243 6480464 fasudil inhibits the reaction [Acetaminophen results in increased expression of ROCK2 protein] CTD PMID:34078832 pentachlorophenol increases expression ISO RGD:11243 6480464 Pentachlorophenol results in increased expression of ROCK2 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:731503 6480464 perfluorooctane sulfonic acid results in decreased expression of ROCK2 mRNA CTD PMID:27153767 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of ROCK2 mRNA CTD PMID:17616710 phenobarbital multiple interactions ISO RGD:11243 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of ROCK2 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:11243 6480464 Phenobarbital results in increased expression of ROCK2 mRNA CTD PMID:19482888 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ROCK2 mRNA CTD PMID:18158353 potassium chromate multiple interactions ISO RGD:731503 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ROCK2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:731503 6480464 potassium chromate(VI) results in decreased expression of ROCK2 mRNA CTD PMID:22079256 , PMID:22714537 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of ROCK2 mRNA] CTD PMID:26476374 quercetin decreases expression ISO RGD:731503 6480464 Quercetin results in decreased expression of ROCK2 mRNA CTD PMID:21632981 raloxifene decreases expression EXP 6480464 Raloxifene Hydrochloride results in decreased expression of ROCK2 mRNA CTD PMID:20970835 ramipril multiple interactions EXP 6480464 [Resveratrol co-treated with Ramipril] inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein], Ramipril inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein] CTD PMID:31062909 resveratrol multiple interactions ISO RGD:11243 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of ROCK2 mRNA] CTD PMID:31298478 resveratrol multiple interactions ISO RGD:731503 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ROCK2 mRNA CTD PMID:23557933 resveratrol multiple interactions EXP 6480464 [Resveratrol co-treated with Ramipril] inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein], Resveratrol inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein] CTD PMID:31062909 sevoflurane multiple interactions EXP 6480464 sevoflurane inhibits the reaction [Guanosine 5'-O-(3-Thiotriphosphate) affects the localization of ROCK2 protein] CTD PMID:12960549 sodium arsenate increases expression ISO RGD:11243 6480464 sodium arsenate results in increased expression of ROCK2 mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:11243 6480464 sodium arsenite results in decreased expression of ROCK2 protein CTD PMID:26135927 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ROCK2 mRNA CTD PMID:35314868 sodium fluoride decreases expression ISO RGD:11243 6480464 Sodium Fluoride results in decreased expression of ROCK2 mRNA CTD PMID:21340527 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ROCK2 protein CTD PMID:31062909 streptozocin multiple interactions EXP 6480464 [Resveratrol co-treated with Ramipril] inhibits the reaction [Streptozocin results in increased expression of ROCK2 protein] more ... CTD PMID:31062909 sunitinib increases expression ISO RGD:731503 6480464 Sunitinib results in increased expression of ROCK2 mRNA CTD PMID:31533062 tetrachloromethane multiple interactions ISO RGD:11243 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ROCK2 mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:11243 6480464 Carbon Tetrachloride results in increased expression of ROCK2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of ROCK2 mRNA] CTD PMID:30783172 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ROCK2 mRNA CTD PMID:30783172 tetrahydropalmatine decreases expression ISO RGD:731503 6480464 tetrahydropalmatine results in decreased expression of ROCK2 protein CTD PMID:20109541 tetraphene multiple interactions ISO RGD:11243 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ROCK2 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ROCK2 mRNA CTD PMID:23411599 Thrombin increases expression EXP 6480464 Thrombin results in increased expression of ROCK2 protein CTD PMID:18287881 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of ROCK2 mRNA CTD PMID:16403772 titanium dioxide multiple interactions ISO RGD:11243 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of ROCK2 mRNA] CTD PMID:31298478 titanium dioxide decreases expression ISO RGD:11243 6480464 titanium dioxide results in decreased expression of ROCK2 mRNA CTD PMID:31298478 tributylstannane increases expression ISO RGD:731503 6480464 tributyltin results in increased expression of ROCK2 mRNA CTD PMID:26314263 Tributyltin oxide increases expression ISO RGD:731503 6480464 bis(tri-n-butyltin)oxide results in increased expression of ROCK2 mRNA CTD PMID:26314263 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of ROCK2 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:731503 6480464 trichostatin A results in increased expression of ROCK2 mRNA CTD PMID:24935251 , PMID:26272509 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of ROCK2 mRNA CTD PMID:27554044 trovafloxacin decreases expression ISO RGD:11243 6480464 trovafloxacin results in decreased expression of ROCK2 mRNA CTD PMID:35537566 tungsten decreases expression ISO RGD:11243 6480464 Tungsten results in decreased expression of ROCK2 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:11243 6480464 Valproic Acid affects the expression of ROCK2 mRNA CTD PMID:17963808 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ROCK2 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:731503 6480464 Valproic Acid results in increased expression of ROCK2 mRNA CTD PMID:28001369 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ROCK2 mRNA CTD PMID:23555832 Y-27632 decreases activity EXP 6480464 Y 27632 results in decreased activity of ROCK2 protein CTD PMID:10998351 Y-27632 multiple interactions EXP 6480464 Y 27632 inhibits the reaction [Carbon Tetrachloride results in increased expression of ROCK2 mRNA] CTD PMID:30783172
